Propanc Biopharma, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $29 | $0 |
Gross Profit | -6 | -3 | 14 | -5 |
EBITDA | -3,654 | -1,503 | -3,811 | -53,958 |
EBIT | -3,660 | -4,532 | -3,816 | -53,963 |
Net Income | -3,091 | -4,837 | -4,071 | -54,067 |
Net Change In Cash | 0 | 0 | 29 | 0 |
Free Cash Flow | -999 | -1,939 | -27 | -136 |
Cash | 561 | 602 | 12 | 50 |
Basic Shares | 13,360 | 12,331 | 11,611 | 4,326 |
Annual Financials
| Values in thousands | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -21 | -17 | -5 | |
EBITDA | -58,339 | -1,262 | -2,235 | -2,139 |
EBIT | -58,359 | -1,283 | -2,257 | -2,140 |
Net Income | -58,923 | -1,821 | -2,661 | -2,658 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -405 | -935 | -1,105 | -1,436 |
Cash | 12 | 21 | 10 | 4 |
Basic Shares | 3,968 | 1 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.39 |
2025-06-30 | -$0.35 |
2025-03-31 | -$12.50 |
2024-12-31 | -$67.65 |
